Noxxon Pharma

Developer of aptamers to target the tumour microenvironment

placeBerlin, Berlin, Germany calendar_todayFounded 1997 groups13 employees language noxxon.com

Registered entities

Investor mix

18 investors on record; lead investors include NGN Capital, Dow Chemical Company, DEWB.

Investor typeCountShare
Venture capital844%
Private equity211%
Bank & private debt422%
Other / undisclosed422%
Coming soon